Background/Objectives: Leishmaniasis, a neglected disease caused by Leishmania spp. including L. amazonensis, urgently requires new treatments. Polyalthic acid (PA), a natural diterpene from Copaifera spp., has previously demonstrated significant antiparasitic potential. This study evaluated the leishmanicidal effects of polyalthic acid (PA), alone and with amphotericin B (AmpB), on L. amazonensis promastigote and amastigote forms. Results: PA showed significant activity against promastigotes, with 50% effective concentration (EC50) values of 2.01 μM at 24 h and an EC50 of 3.22 μM against amastigotes after 48 h. The PA and AmpB combination exhibited a synergistic effect on both forms without inducing cytotoxicity or hemolysis. Morphological changes in promastigotes, including vacuole formation and cell rounding, were more pronounced with the combination. Conclusions: These findings suggest that PA and AmpB together could form a promising new treatment strategy against Leishmania infections, offering enhanced efficacy without added toxicity.
6 August 2025 in Orbital: the Electronic Journal of Chemistry
This paper describes the obtention of fourteen derivatives from four natural labdane diterpenes isolated from Copaifera oleoresin, named ent-copalic acid (1), ent-3b-acetoxy copalic acid (2), ent-3b-hydroxy copalic acid (3) and ent-agathic acid (4). All eighteen compounds, derivatives and precursors, were assayed against the promastigote form of Leishmania amazonensis and trypomastigote forms of Trypanosoma cruzi, revealing two promising compounds with leishmanicidal activity (IC50 = 5.94 mM and 5.31 mM) and three promising compounds with trypanocidal activity, two of them (IC50 = 13.31 mM and IC50 = 15.05 mM) displaying similar activity as the reference drug (IC50 = 13.12 mM) and one of them being even more potent with an IC50 = 0.425mM.
In this paper is described the obtention of fourteen derivatives from four natural labdane diterpenes isolated from Copaifera oleoresin, named ent-copalic acid (1), ¬ent-3beta-acetoxy copalic acid (2), ent-3beta-hydroxy copalic acid (3) and ent-agathic acid (4). All eighteen compounds were assayed against promastigote form of Leishmania amazonensis and trypomastigote forms of Trypanosoma cruzi, revealing two promising compounds related to leishmanicidal activity (IC50 = 5.94 micromolar and 5.31 micromolar) and three promising compounds with trypanocidal activity, two of them (IC50 = 13.31micromolar and IC50 = 15.05micromolar) displaying similar activity as the reference drug (IC50 = 13.12micromolar) and one of them even more potent with IC50 = 0.425micromolar.
Five 2-aroylbenzofuranes were synthesized by condensation between α-bromoacetone and an ortho-hydroxybenzaldehyde or ortho-hydroxy-acetophenone and evaluated for their in vitro antischistomal effects against adult Schistosoma mansoni worms. Below 200 µg/mL, none of the tested 2-aroylbenzofurans killed adult S. mansoni worms. On the other hand, at 200 µg/mL all the tested compounds reduced the motor activity of adult S. mansoni worms after treatment for 72 h. At 200 µg/mL, compound 1 was the only one to decrease the motor activity of 67% of the worms after incubation for 24 h. The methyl group at C6 and the nature of the substituent at ring A play important roles in the efficacy of 2-aroylbenzofurans in reducing the worm motor activity.